Parallel Advisors, LLC Atea Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$5.5 - $9.19 $192 - $321	-35 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$7.67 - $44.59 $421 - $2,452	-55 Reduced 61.11%	35 $0
Q3 2021 Nov 02, 2021	BUY	$21.33 - $35.06 $1,002 - $1,647	47 Added 109.3%	90 $3,000
Q2 2021 Aug 06, 2021	BUY	$19.22 - $59.08 $826 - $2,540	43 New	43 $1,000

111

52.3M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $276M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.